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Abstract
Background: Health-related and disease-specific quality of life (HRQoL) has been increasingly valued as relevant
clinical parameter in cystic fibrosis (CF) clinical care and clinical trials. HRQoL measures should assess – among other
domains – daily functioning from a patient’s perspective. However, validation studies for the most frequently used
HRQoL questionnaire in CF, the Cystic Fibrosis Questionnaire (CFQ), have not included measures of physical activity
or fitness. The objective of this study was, therefore, to determine the cross-sectional and longitudinal relationships
between HRQoL, physical activity and fitness in patients with CF.
Methods: Baseline (n = 76) and 6-month follow-up data (n = 70) from patients with CF (age ≥12 years, FEV1 ≥35%)
were analysed. Patients participated in two multi-centre exercise intervention studies with identical assessment
methodology. Outcome variables included HRQoL (German revised multi-dimensional disease-specific CFQ (CFQ-R)),
body composition, pulmonary function, physical activity, short-term muscle power, and aerobic fitness by peak
oxygen uptake and aerobic power.
Results: Peak oxygen uptake was positively related to 7 of 13 HRQoL scales cross-sectionally (r = 0.30-0.46). Muscle
power (r = 0.25-0.32) and peak aerobic power (r = 0.24-0.35) were positively related to 4 scales each, and reported
physical activity to 1 scale (r = 0.29). Changes in HRQoL-scores were directly and significantly related to changes in
reported activity (r = 0.35-0.39), peak aerobic power (r = 0.31-0.34), and peak oxygen uptake (r = 0.26-0.37) in 3 scales
each. Established associates of HRQoL such as FEV1 or body mass index correlated positively with fewer scales
(all 0.24 < r < 0.55).
Conclusions: HRQoL was associated with physical fitness, especially aerobic fitness, and to a lesser extent with
reported physical activity. These findings underline the importance of physical fitness for HRQoL in CF and provide
an additional rationale for exercise testing in this population.
Trial registration: ClinicalTrials.gov, NCT00231686
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Background
In cystic fibrosis (CF) patient care and in CF-related
clinical trials, patient reported outcomes such as health-
related quality of life (HRQoL) have been increasingly
valued as relevant clinical parameter over the last two
decades [1,2]. HRQoL even allowed a prediction of sur-
vival in patients with CF [3].
HRQoL measures should assess – among other do-
mains – daily functioning from a patient’s perspective
[4,5]. Thus, one would expect a direct association of
HRQoL with physical activity and physical fitness. In
healthy people, a positive relationship has consistently
been found between physical activity [6] or aerobic fit-
ness [7] and HRQoL, indicating their significant contri-
bution to perceived well-being. Research is scarce which
has been done to explore the importance of their role in
people with chronic conditions such as CF. The few
existing studies showed moderate to strong direct corre-
lations between HRQoL based on the non disease-
* Correspondence: hebestreit@uni-wuerzburg.de
1Pediatric Department, University of Würzburg, Würzburg, Germany
8Universitäts-Kinderklinik, Josef-Schneider-Str. 2, 97080 Würzburg, Germany
Full list of author information is available at the end of the article
© 2014 Hebestreit et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited.
Hebestreit et al. BMC Pulmonary Medicine 2014, 14:26
http://www.biomedcentral.com/1471-2466/14/26
specific Quality of Well-being Scale and objectively mea-
sured physical activity [8] or peak oxygen uptake [9]. How-
ever, the use of generic HRQoL questionnaires in CF may
be questioned as they do not include disease-specific
aspects [4,10].
The revised Cystic Fibrosis Questionnaire (CFQ-R) is
a validated, multi-dimensional disease-specific measure
to assess generic and disease-specific domains of HRQoL
in CF that is available in several languages including
English and German [5,11]. To our knowledge, only one
relatively small cross-sectional study has assessed the as-
sociation between HRQoL-scales and aerobic fitness so far
[12] and found a positive relationship between VO2peak
and several scales, which did not persist after adjusting for
age and gender [12].
Based on the scarce cross-sectional [12] and com-
pletely lacking longitudinal data in CF, the objective
of this study was to determine the cross-sectional and
longitudinal relationships between HRQoL as assessed
by the CFQ-R, and physical activity and fitness in this
population. Based on the studies using the Quality of
Well-being Scale we hypothesised that there would be
significant and positive associations between HRQoL
scales and measures of physical activity and physical
fitness cross-sectionally and longitudinally.
Methods
Study population
Data for this project were taken from two exercise inter-
vention studies in CF that were designed as twin studies
with different objectives but identical assessment method-
ology: a German study with a partially supervised training
group and a control group, and a Swiss study with a su-
pervised aerobic training group, a supervised strength
training group and a control group [13,14]. Patients with
CF, aged 12 years and older and with an FEV1 of at least
35% of predicted, were recruited from German CF centers
in Frankfurt, Hannover, and Würzburg (n = 38), and from
the German-speaking provinces of Switzerland (n = 39).
The respective ethics committees of the participating
centers (Frankfurt, Hannover, Würzburg for Germany and
Zürich for Switzerland) approved the study protocol and
procedures. Written informed consent was obtained from
the patients and their guardians, if the patients were under
18 years of age.
At the end of the baseline assessments, patients were
randomly allocated to an intervention (n = 23) or a
control group (n = 15) in Germany and to a strength-
training (n = 12), an aerobic training (n = 17) and a control
(n = 10) group in Switzerland by drawing lots out of
an opaque bag which contained 24 lots intervention and
16 lots control in Germany, and 20 lots each for the
aerobic training, strength training and the control group
in Switzerland. The initial goal of recruiting 60 Swiss
CF patients could not be reached. One male 16-year-old
Swiss patient did not complete the quality of life ques-
tionnaire at baseline so that his data were also not in-
cluded in this analysis. Until the follow-up visit after
6 months, three patients from Germany (all from the
intervention group) and three patients from Switzerland
(two from the aerobic training group, and one from the
strength-training group) decided to discontinue their
participation in the study.
Study design
Patients were seen in their respective centre at study entry
(Germany: December 2000 to March 2001; Switzerland:
September 1999 to June 2001), and after 6 months. All
measurements were taken while participants were in
stable clinical condition. If needed, visits were postponed
until the clinical status was stable or intravenous treat-
ment was over for at least 4 weeks. At each visit, the
following outcome variables were determined: HRQoL,
reported physical activity, height, weight, and body mass
index, body composition (percent body fat), pulmonary
function (forced expiratory volume in 1 s – FEV1), short-
term muscle power, maximal aerobic work rate, and peak
oxygen uptake (VO2peak). Within a period of ± 3 weeks
around the above visits, time spent in moderate-and-
vigorous physical activity (MVPA) was determined by
accelerometry.
Procedures
At baseline and at 6-months follow-up, HRQoL was
assessed by the adolescent and adult versions of the revised
German CFQ-R questionnaire [11]. This self-administered,
disease-specific health-related questionnaire has five gen-
eric scales (Physical functioning, Vitality, Emotional state,
Social limitations, Role limitations), four disease-specific
scales (Feelings of embarrassment about symptoms, Eating
disturbance, Body image, Treatment burden), one scale on
Subjective general health perception, and three scales
assessing Respiratory symptoms, Digestive symptoms and
Weight problems. For each scale, the score is given on a
0- to 100-point scale with higher scores denoting higher
HRQoL, i.e. better functioning or health perception and
less problems or symptoms.
The German CFQ-R [11] includes a scale on “Embar-
rassment’ which has been omitted from the United
States CFQ-R [5]. Reported scale consistencies of the
German CFQ-R are satisfactory (Cronbach α > 0.7) for
all scales except for the ‘Digestive symptom’ scale (α =
0.66) [11]. Test-retest reliability was high for all
HRQoL-scales in the previous version of that instrument
(intraclass correlation coefficients 0.76-0.92) [11]. Con-
struct validity was shown by significant correlation coeffi-
cients between most CFQ-R scales and FEV1 and for
some scales with BMI [11]. Significant improvements in
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most CFQ-R scales following a rehabilitation program
have demonstrated responsiveness of the German CFQ-R
[11]. In general, validation studies for the German and US
CFQ-R have shown similar reliability, validity and respon-
siveness [5,11].
BMI was calculated from height and body mass, and
body adiposity from skinfold thickness that was con-
verted into percent body fat (% BF) [15,16]. FEV1 and
FVC were determined by standard spirometry and ex-
pressed as % predicted [17]. Short-term muscle power
was assessed on a calibrated mechanically braked cycle
ergometer using the 30-sec Wingate test protocol [18]
(in Germany: Monark 834 E Ergomedic ergometer
(Varberg, Sweden); in Switzerland: Fleisch cycle ergom-
eter (Metabo, Switzerland)). There is good agreement
among ergometers albeit tested in young children [19].
For each Wingate test, braking force was calculated from
body mass using existing equations [18] and modified
up to 10% depending on the performance in two short
practice runs. Average power generated during the
Wingate test was chosen as indicator of muscle power
and expressed relative to body weight.
After a rest period of at least 30 min, subjects completed
a continuous incremental cycling task to volitional fatigue
following the protocol proposed by Godfrey et al. [20].
Work rate was increased every minute by 15 to 20 Watts,
depending on patient´s height and physical fitness.
German patients were tested using a calibrated Monark
834 E cycle ergometer and metabolic cart (CPX/D,
MedGraphics, St Paul, MN) while Swiss patients used
a Fleisch cycle ergometer and a Quark metabolic cart
(Cosmed, Rome, Italy) The metabolic carts were calibrated
before each exercise test with two gases of known con-
centrations. Stability of the O2- and CO2-sensors was
verified after each test. Maximal aerobic power (Wmax)
was taken as the power maintained over the final com-
pleted 1-minute stage during the test. Peak oxygen uptake
(VO2peak) was determined as highest VO2 over 30 s dur-
ing the test and expressed relative to body weight. Wmax
and VO2peak were also expressed in % predicted [20,21].
The values expressed in % predicted were used for further
analyses.
Total time per week reported in the categories ‘hard’
and ‘very hard’ of the 7-day Physical Activity Recall
Questionnaire [22,23], translated into German was used
as measure of reported activity. This questionnaire has
recently been validated for patients with CF [24].
Within ± 3 weeks to the baseline and follow-up assess-
ments, patients wore a MTI/CSA 7164 accelerometer
(MTI Health Services, Fort Walton Beach, FL) for 7 con-
secutive days at the right hip with an epoch time set to
60 s. Periods of 60 min or more with zero readings were
excluded from analysis. Data were included if a patient
had completed at least 5 days of recordings with at least
10 hours of valid data per day. Time spent in moderate
and vigorous physical activity (MVPA) was defined based
on cut-offs above 1000 counts · min-1, respectively, and
expressed in hours per week [13,25].
Details of the interventions are provided in the respect-
ive publications [13,14]. Briefly, patients of the interven-
tion groups consented to add regular strenuous exercise
to their baseline activities for 6 months. In the Swiss study,
weekly exercise was increased by three times 30 min of
supervised strength training in a fitness centre (whole body
strengthening with one set of 15 repetitions) or aerobic
training (on a stationary cycle ergometer at 65% of
maximal oxygen uptake) in a fitness centre or at home.
Supervision of the training was done by the same persons
throughout the study; in the aerobic training group by
a student involved in the study, in the strength training
group by staff of the respective fitness centers, in the
German study with regular phone calls by one investiga-
tor (StKi). In the German study, patients of the inter-
vention group agreed to add three times 60 min per
week of any sport activity to their routine activities.
They could freely choose the type of activity for each
exercise session.
Analyses
Data are described as means ± SD or median ± interquar-
tile range (IQR). HRQoL data are presented in both ver-
sions due to comparability to other studies in this area.
Non-parametric tests were used to assess differences
among groups and effects of potential predictors on the
ordinal and discontinuous HRQoL scales. Differences in
baseline characteristics according to gender and country
were compared by rank sum test. Associations between
HRQoL scales and anthropometry, lung function, phys-
ical activity and fitness were tested by Spearman rank
correlation analyses. Likewise, Spearman rank correl-
ation analyses were used to determine the relationships
between the changes on HRQoL scales over 6 months
and the changes in the above predictors over this time
period. We also tested associations between HRQoL-
scales and BMI, body fat, FEV1, physical activity, and
anaerobic and aerobic performance at baseline and
changes over 6 months by linear regression models
with adjustments for age, gender, group allocation
(training vs no training) and nationality. Since HRQoL
scores are ordinal variables with a few discrete stages,
bootstrapping was used to estimate standard errors of
the regression-coefficients. We finally used the simple
correlation models as results were similar when using
simple correlation analyses or multiple linear regression
models with bootstrapping adjusting for best and most
plausible set of predictors (age, gender, and nationality for
the cross-sectional analyses; age, gender, nationality, train-
ing vs no training, strength training vs other modalities of
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training for the longitudinal analyses with bootstrapping
(see Additional file 1). Statistical significance was accepted
at p < 0.05.
Results
Data of 76 patients were available for cross-sectional
analyses while 70 patients contributed data to longitu-
dinal analyses covering 6 months (Table 1).
Tables 2 and 3 describe baseline characteristics and
their respective changes over 6 months of the popula-
tion. Male and female patients differed significantly
in their baseline anthropometric variables for reported
physical activity and muscle power. Swiss patients were
significantly older than the German patients (21.6 ± 5.4
vs. 19.6 ± 6.0 years, p < 0.05) and had a lower aerobic
power (77 ± 13 vs 84 ± 15% predicted, p < 0.05) and less
body fat (13.9 ± 7.2 vs 17.5 ± 7.1%, p < 0.05). Except for the
HRQoL scale ‘Role limitations’ which was significantly
lower in females at baseline, there were no significant
differences in HRQoL scales between genders, Swiss and
German patients (data not shown), nor among the five
intervention arms (data not shown) cross-sectionally nor
over 6 months with one exception. There was a difference
in changes in ‘Vitality’ among the five treatment groups
which could be attributed to a significant decrease in
‘Vitality’ scores in the weight training group compared
to the partially supervised training group (-8.3 (-16.7-0.0)
vs. 0.0 (-8.3-8.3), p < 0.05).
Relationship between HRQoL and established covariates
Cross-sectional and longitudinal correlation analyses are
shown in Table 4. At baseline, patient’s age was correlated
with more ‘Respiratory symptoms’ (r = -0.32, p < 001).
BMI was positively related to the HRQoL scale ‘Eating dis-
turbance’ (i.e. less eating disturbance), ‘Body image’ and
‘Weight problems’ (i.e. less weight problems). Body fat was
directly related to the ‘Body image’ and ‘Weight problems’
scales. FEV1 was directly associated with ‘Physical func-
tioning’ , ‘Health perception’ and ‘Respiratory symptoms’
scores, i.e. increasing FEV1 values were associated with
increasing values of physical functioning, health percep-
tion and decreasing respiratory symptoms (Table 4A).
Changes in BMI over 6 months were directly associated
with changes in ‘Health perception’ and ‘Weight prob-
lems’ scales (Table 4B), while changes in FEV1 were
directly related to changes in ‘Feelings of embarrassment’
scores. The strength of the associations were moderate
and ranged from r = 0.24-0.55.
Relationship between HRQoL and physical activity or
fitness
Cross-sectional and longitudinal relationships between
HRQoL, physical activity and fitness are shown in Table 4.
The HRQoL scale ‘Social role’ (i.e. a high value denotes
little impairment in social role) was directly related to
reported physical activity. Changes in reported physical
activity over 6 months were directly related to changes
in the ‘Role limitations’, ‘Feelings of embarrassment’, and
‘Weight problems’ scales. Belonging to the strength
training group was associated with a lower HRQoL-
scale ‘Vitality’ (data not shown). Objectively measured
physical activity indices showed no significant associations
with any HRQoL scale, neither in the cross-sectional nor
in the longitudinal data analyses.
In the cross-sectional analyses, muscle power was
directly associated with the HRQoL-scales ‘Physical
functioning’ , ‘Vitality’ , ‘Role imitations’ , and ‘Digestive
symptoms’ while no associations were observed be-
tween changes in muscle power and changes in any
HRQoL-scale in the longitudinal analyses. Aerobic
power (Wmax) directly correlated with 4 HRQoL scales
cross-sectionally and a change in aerobic power over
6 months was directly associated with ‘Vitality’ , ‘Role
limitations’ and ‘Weight problems’ scales. VO2peak even
positively correlated with 7 of the 13 HRQoL scales
cross-sectionally, including 5 disease-oriented scales.
Furthermore, a change in VO2peak over 6 months dir-
ectly correlated with the HRQoL-scales ‘Feelings of em-
barrassment’, ‘Health perception’ and ‘Weight problems’.
The strength of the associations were moderate and
ranged from r = 0.25-0.46.
Discussion
In this study we found that aerobic fitness and reported
physical activity were directly and moderately associated
with HRQoL scales cross-sectionally and to a lesser ex-
tent also longitudinally in a sample of 76 patients with CF
and mild to moderate disease. Established determinants of
HRQoL such as FEV1 and BMI correlated with fewer
Table 1 Number of patients with complete data at
baseline and 6 months for each indicated measurement
Baseline 6-month
follow-up
Both
Body mass index (kg/m2) 76 70 70
FEV1 (% predicted) 76 70 70
Reported activity
(hours per week)
71 68 64
Measured MVPA (hours/week) 70 54 53
Mucle power (W/kg) 74 70 68
Wmax (% predicted) 76 69 69
VO2 peak (% predicted) 73 69 66
Quality of life* 76 70 70
FEV1 – forced expiratory volume in 1 second; MVPA – moderate-and-vigorous
physical activity; Wmax – maximal aerobic power; VO2peak – peak oxygen
uptake. *for the scale role limitations only 66 patients provided data at baseline,
59 at the 6-months follow-up and 52 had complete data at both time points to
calculate changes.
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scales. Based on scarce data in the literature looking at the
relation between HRQoL and aerobic fitness and physical
activity in CF, these findings are most important and
relevant from a clinical perspective. The novel aspect of in-
cluding longitudinal associations strengthens the findings.
HRQoL in our study was similar to that reported for
patients with mild to moderate disease severity [5,11]. In
contrast to the German [11] and American [5] validation
studies of the CFQ-R, data of patients with an FEV1
below 35% predicted were not included in our analyses
which reduced the range of FEV1 in our project (35-107%
predicted) compared to the respective validation studies
(Germany: 12-106% predicted; United States: 17-130%
predicted) [5,11]. Possibly as a consequence of the smaller
range in FEV1, surprisingly few significant associations
were observed between HRQoL-scales and FEV1 in the
current project [5,11]. Nevertheless, the power of our study
was sufficient to detect clear and consistent positive associ-
ations between physical fitness and multiple HRQoL-scales.
Relationship between HRQoL and physical activity
In contrast to our hypothesis, but in accordance to another
comparable study in children with CF [12] no significant
associations were observed between objectively measured
physical activity and any HRQoL-scale. For reported phys-
ical activity, only one significant direct correlation was
detected with the scale ‘Role limitations’ cross-sectionally
(Table 4A). In a previous cross-sectional study, physical
activity was found to correlate quite strongly with Qual-
ity of Well-being reported by patients with CF [8]. The
discrepancy to our findings might reflect differences in
the approach to determine HRQoL between the generic
Quality of Well-being Scale and the multi-dimensional
disease-specific CFQ-R. The Quality of Well-being Scale
asks specifically whether or not the patient performs cer-
tain activities while the CFQ-R assesses the patient’s feel-
ings and difficulties while performing activities.
Changes in reported physical activity, however, were
positively associated with changes in three scales of the
CFQ-R in the current study, namely ‘Role limitations’ ,
‘Feelings of embarrassment’ , and ‘Weight problems’.
This is important, as it shows that an increase in phys-
ical activity could increase HRQoL even after just
6 months. Other studies have also shown significant
positive relationships between self-reported physical
activity and HRQoL in healthy adults [6] or patients
with chronic obstructive pulmonary disease [26].
While reported physical activity showed some direct
association with HRQoL, objectively measured activity
did not. This finding is difficult to interpret. Possibly,
specific aspects of our study design have obscured a
significant relationship: Accelerometry was performed
within a given period of three weeks before or after as-
sessment of HRQoL, while anthropometry, pulmonary
function assessment, exercise testing, and completion of
activity and quality of life questionnaires were all done on
the same day. It is possible that physical activity assessed
by accelerometry over a few days did not mirror phys-
ical activity a few weeks earlier or later which may have
been confounded by short-term alterations in disease
state or weather conditions [27]. Furthermore, the ap-
proach chosen to analyze accelerometer data including
the selection of epoch times, definition of non-wear
time or cutoffs for MVPA has been shown to influence
the results [28] and may also have contributed to the
attenuated relation between physical activity and HRQoL.
Furthermore, due to incomplete accelerometry data,
sample size for the respective analyses and thus statistical
Table 2 Subjects' characteristics at baseline and changes over 6 months according to gender
Baseline Change over 6 months
Female Male Total Female Male Total
Number 37 39 76 34 36 70
Age (years) 19.5 ± 5.5 21.6 ± 5.9 20.6 ± 5.8 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.1
Body mass index (kg/m2) 19.9 ± 2.5 19.8 ± 2.9 19.8 ± 2.7 –0.1 ± 1.2 0.1 ± 0.7 0.0 ± 1.0
FEV1 (% predicted) 72.3 ± 20.3 65.1 ± 17.4 68.6 ± 19.1 –1.3 ± 11.4 0.2 ± 11.3 –0.5 ± 11.3
Reported activity (hours/week) 5.8 ± 6.4 9.5 ± 10.6* 7.7 ± 9.0 1.1 ± 7.4 –2.5 ± 11.0 –0.7 ± 9.5
Measured MVPA (hours/week) 9.2 ± 3.8 11.2 ± 5.1 10.1 ± 4.5 –0.5 ± 4.7 –1.2 ± 3.4 –0.8 ± 4.1
Muscle power (W/kg) 5.6 ± 0.7 7.3 ± 1.1*** 6.5 ± 1.3 –0.1 ± 0.8 –0.2 ± 0.7 –0.2 ± 0.7
Wmax (W) 152 ± 28 191 ± 44 172 ± 42 3 ± 23 14 ± 28 9 ± 26
Wmax (% predicted) 102.7 ± 19.3 94.7 ± 17.1 98.6 ± 18.5 1.0 ± 015.7 5.4 ± 13.6 3.3 ± 14.7
VO2peak (ml/kg/min) 33.9 ± 6.6 41.0 ± 6.7 37.4 ± 7.5 0.3 ± 5.4 1.6 ± 5.1 0.9 ± 5.2
VO2peak (% predicted) 82.6 ± 16.3 78.0 ± 13.2 80.3 ± 14.9 0.5 ± 13.9 3.0 ± 10.8 1.8 ± 12.4
Data are mean ± standard deviation (SD). Abbreviations: FEV1 forced expiratory volume in 1 second, MVPA moderate–and–vigorous physical activity,
Wmax maximal aerobic power, VO2peak peak oxygen uptake. *, **, *** denote a significant difference between female and male patients at the p < 0.05,
p < 0.01 and p < 0.001 level, respectively.
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power was lower than for other variables. Further studies
are required to explore the associations between object-
ively measured physical activity and HRQoL in CF.
Relationship between HRQoL and physical fitness
The main finding of the present study was that physical
fitness, mainly aerobic fitness, was positively associated
with HRQoL cross-sectionally and longitudinally. This
observation is in line with the positive association be-
tween changes in aerobic fitness and changes in Quality
of Well-being reported by others [29] and the direct
associations between VO2peak and the HRQoL-scales
‘physical functioning’, ‘emotional functioning’, ‘social func-
tioning’, and ‘treatment burden’ observed by Groenevelt
et al. [12]. Furthermore, the significant and positive
correlations between indicators of aerobic fitness and
the disease-specific HRQoL-scales were as strong and
sometimes stronger than the associations of these
scales with more traditional measures of disease severity
such as age, FEV1 or body composition. This finding un-
derlines the importance of a good physical fitness for
HRQoL in CF especially in disease-specific scales, and
therefore the importance of physical fitness assessments
in patients with CF. In addition, our findings strengthen
the construct validity of the CFQ-R.
After adjusting for age and gender, the only other
cross-sectional study testing the relation between phys-
ical activity, physical fitness, and HRQoL scales did not
find any significant correlation [12]. This may be due to
the much smaller sample size in their study group and
Table 3 Health-related quality of life (A. median ± IQR; B. means ± SD) at baseline and changes over 6 months
according to gender
A. Medians ± IQR Baseline Change over 6 months
Female Male Total Female Male Total
Physical functioning 87.5 (75.0–95.8) 91.7 (75.0–100.0) 87.5 (75.0–95.8) –3.1 (–8.3–5.2) 0.0 (0.0–7.3) 0.0 (–5.2–5.2)
Vitality 58.3 (50.0–70.8) 66.7 (50.0–75.0) 58.3 (50.0–75.0) 0.0 (–8.3–8.3) 0.0 (–8.3–14.6) 0.0 (–8.3–8.3)
Emotional state 86.7 (70.0–93.3) 86.7 (80–93.3) 86.7 (73.3–93.3) 0.0 (–6.7–8.3) 0.0 (–6.7–5.0) 0.0 (–6.7–6.7)
Social limitations 83.3 (58.3–91.7) 75.0 (58.3–91.7) 75.0 (58.3–91.7) 0.0 (–12.5–12.5) 0.0 (–8.3–6.3) 0.0 (–8.3–8.3)
Role limitations 87.5 (75.0–100.0) 100.0 (87.5–100.0)* 100.0 (87.5–100.0) 0.0 (0.0–12.5) 0.0 (0.0–0.0) 0.0 (0.0–9.4)
Feelings of embarrassment 83.3 (66.7–100.0) 77.8 (66.7–100.0) 77.8 (66.7–100.0) 0.0 (–11.1–11.1) 0.0 (–8.3–11.1) 0.0 (–11.1–11.1)
Body image 77.8 (66.7–88.9) 77.8 (55.6–88.9) 77.8 (66.7–88.9) 0.0 (–2.8–11.1) 0.0 (–11.1–8.3) 0.0 (–11.1–11.1)
Eating disturbances 100.0 (83.3–100.0) 100.0 (66.7–100.0) 100.0 (66.7–100.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Treatment burden 66.7 (50.0–83.3) 66.7 (50.0–83.3) 66.7 (50.0–83.3) 0.0 (–8.3–16.7) 0.0 (–16.7–16.7) 0.0 (–16.7–16.7)
Health perception 63.6 (54.5–81.8) 72.7 (63.6–90.9) 72.7 (62.8–81.8) 0.0 (–9.1–9.1) 0.0 (–7.1–9.1) 0.0 (–9.1–9.1)
Weight problems 100.0 (66.7–100.0) 66.7 (58.3–100.0) 100.0 (66.7–100.0) 0.0 (–25.0–0.0) 0.0 (–33.0–0.0) 0.0 (–33.0–0.0)
Respiratory symptoms 72.2 (64.3–91.0) 66.7 (61.9–76.2) 71.4 (61.9–77.8) 0.0 (–14.3–4.8) 0.0 (–9.5–9.5) 0.0 (–9.5–7.9)
Digestive symptoms 83.3 (66.7–100.0) 83.3 (66.7–100.0) 83.3 (66.7–100.0) 0.0 (0.0–16.7) 0.0 (–8.3–0.0) 0.0 (0.0–16.7)
B. Means ± SD Baseline Change over 6 months
Female Male Total Female Male Total
Physical functioning 82.9 ± 16.2 85.6 ± 15.1 84.3 ± 15.6 –1.3 ± 13.3 2.2 ± 9.0 0.5 ± 11.4
Vitality 59.9 ± 16.2 63.2 ± 15.1 61.6 ± 15.6 –0.2 ± 16.6 3.0 ± 15.3 1.4 ± 15.9
Emotional state 81.4 ± 14.8 84.4 ± 15.4 83.0 ± 15.1 1.4 ± 16.1 –1.4 ± 9.7 0.0 ± 13.2
Social limitations 76.4 ± 19.0 72.0 ± 23.2 74.1 ± 21.2 –1.0 ± 23.5 0.6 ± 11.6 –0.2 ± 18.2
Role limitations 89.5 ± 12.5 95.0 ± 9.7* 92.4 ± 11.4 2.2 ± 14.9 –2.2 ± 18.9 –0.2 ± 17.2
Feelings of embarressment 77.2 ± 23.9 76.1 ± 23.3 76.6 ± 23.4 2.9 ± 20.0 1.2 ± 18.2 2.0 ± 19.0
Body image 77.2 ± 18.8 72.9 ± 23.9 75.0 ± 21.5 1.9 ± 17.9 –1.7 ± 15.8 0.0 ± 16.8
Eating disturbances 89.4 ± 17.0 86.8 ± 21.4 88.0 ± 19.3 1.0 ± 12.5 –0.5 ± 18.9 0.2 ± 16.0
Treatment burden 63.0 ± 18.1 65.0 ± 17.0 64.0 ± 17.8 2.5 ± 19.1 0.7 ± 19.6 1.6 ± 19.2
Health perception 67.5 ± 18.1 70.4 ± 19.5 69.0 ± 18.8 1.4 ± 19.3 0.7 ± 15.4 1.0 ± 17.3
Weight problems 83.8 ± 21.7 71.9 ± 32.4 77.8 ± 28.1 –8.3 ± 35.9 –7.1 ± 33.1 –7.7 ± 34.2
Respiratory symptoms 69.3 ± 15.8 67.6 ± 10.3 68.5 ± 13.3 –3.1 ± 19.0 –0.9 ± 10.0 –2.0 ± 15.1
Digestive symptoms 83.8 ± 14.4 83.3 ± 18.2 83.6 ± 16.3 4.5 ± 18.3 –1.0 ± 15.0 1.8 ± 16.8
*Denotes a significant difference between female and male patients at the p < 0.05 level.
Hebestreit et al. BMC Pulmonary Medicine 2014, 14:26 Page 6 of 9
http://www.biomedcentral.com/1471-2466/14/26
the large age ranges as important confounders. Fur-
thermore, the expression of the aerobic fitness per kg
bodyweight rather than per predicted value may have
“penalized” those who maintained body weight (leading
to lower VO2peak per kg values) and “favorized” those
who lost bodyweight (leading to higher VO2peak per kg
values) – the opposite scenario from what would be
expected from a clinical perspective. Indeed, when ana-
lyzing our data with a multiple regression model and
adjusting for age, gender and nationality, direct rela-
tionships between VO2peak and 9 HRQoL-scales were
observed (see Additional file 1).
At first sight it seems surprising that the HRQoL-
scales ‘Physical functioning’ and ‘Respiratory symptoms’
were not responsive to changes in physical fitness. It is
notable, however, that the actual data were taken from a
training study and not from a longitudinal set of obser-
vational data. Thus, the patients included in this project
were willing and felt generally capable of participating
in regular exercise. This approach might have affected
HRQoL perception related to changes in physical fitness.
Moreover, several training studies have shown that phys-
ical conditioning may improve physical fitness while FEV1
remains relatively unaffected [12,30]. Thus, although there
Table 4 Relationships of baseline (A) and changes over 6 months (B) between quality of life scales and BMI, FEV1,
physical activity measures, muscle power, and aerobic capacity
A. Baseline
BMI Body fat FEV1 Reported activity Measured MVPA Muscle power Wmax VO2peak
Physical functioning 0.098 –0.08 0.264* 0.2 0.118 0.320** 0.237* 0.369**
Vitality 0.055 –0.043 –0.034 0.213 0.012 0.304** 0.145 0.201
Emotional state 0.014 –0.092 0.024 0.184 0.035 0.176 0.153 0.204
Social limitations –0.033 0.082 –0.066 0.212 –0.182 –0.031 0.06 0.059
Role limitations 0.03 –0.207 0.176 0.292* 0.222 0.296* 0.195 0.315*
Feelings of embarrassment 0.065 0.148 0.161 0.155 0.021 –0.051 0.072 0.174
Body image 0.435*** 0.306** 0.217 –0.029 0.068 –0.171 0.092 0.164
Eating disturbances 0.373** 0.117 0.141 –0.006 0.111 0.034 0.167 0.297*
Treatment burden 0.096 –0.027 0.046 0.066 –0.134 0.137 0.211 0.177
Health perception 0.18 –0.023 0.283* 0.187 0.163 0.13 0.284* 0.396***
Weight problems 0.491*** 0.228* 0.147 –0.073 0.012 –0.08 0.350** 0.456***
Respiratory symptoms 0.027 0.114 0.302** 0.106 0.057 0.041 0.204 0.424***
Digestive symptoms 0.057 –0.074 0.096 0.099 0.183 0.245* 0.307** 0.376**
B. Changes over 6 months
Δ BMI Δ Body
fat
Δ FEV1 Δ Reported
activity
Δ Measured
MVPA
Δ Muscle
power
Δ
Wmax
Δ
VO2peak
Δ Physical functioning –0.013 0.02 0.026 0.044 –0.198 0.012 0.056 0.114
Δ Vitality* 0.189 0.16 0.094 0.227 –0.16 0.057 0.305* 0.176
Δ Emotional state 0.154 0.174 0.073 –0.027 –0.143 0.097 0.137 0.002
Δ Social limitations –0.134 0.075 0.1015 –0.027 –0.11 0.051 0.13 0.243
Δ Role limitations 0.123 –0.078 –0.077 0.393** 0.124 0.192 0.307* 0.267
Δ Feelings of embarrassment 0.109 0.035 0.244* 0.389** 0.037 –0.025 0.219 0.255*
Δ Body image 0.1 0.139 0.148 0.195 0.012 0.178 –0.028 0.02
Δ Eating disturbances 0.066 0.19 0.21 0.089 0.091 0.171 0.067 0.048
Δ Treatment burden 0.133 0.029 –0.053 –0.094 –0.073 0.019 0.158 0.043
Δ Health perception 0.325** 0.156 0.191 –0.049 –0.24 –0.054 0.137 0.247*
Δ Weight problems 0.545*** 0.19 0.162 0.345** –0.189 –0.125 0.340** 0.366**
Δ Respiratory symptoms 0.177 0.015 0.205 0.069 –0.112 –0.104 0.041 0.112
Δ Digestive symptoms –0.04 –0.081 0.027 –0.012 –0.039 –0.066 0.056 –0.004
Data are Spearman rank correlation coefficients. A positive correlation indicates that a higher level of physical activity or fitness is associated with a better QoL.
Abbreviations: MVPA moderate–and–vigorous physical activity, Wmax maximal aerobic power, VO2peak peak oxygen uptake.
Significant correlation coefficients are highlighted by bold characters.
*– p < 0.05; **– p < 0.01; ***– p < 0.001.
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was a significant direct correlation between peak oxygen
uptake and the ‘Respiratory symptom’ scale at baseline,
the subjective and objective respiratory situation in many
patients might not have changed enough to be perceived
positively despite improvements in aerobic fitness.
One limitation of the current project is the relatively
small number of patients in the five treatment condi-
tions that limits statistical power in detecting effects of
the different treatment regimens on HRQoL. Nevertheless,
supervised strength training three times per week over six
months was associated with significant decreases in the
HRQoL-scale ‘Vitality’, i.e. less vitality. It is possible that
the supervised strength training might have been too
strenuous to maintain or even improve ‘Vitality’ despite
improvements in aerobic fitness and pulmonary function
[14]. A decrease in feelings of energy and an increase in
perceived fatigue were observed in competitive swimmers
progressively increasing their training volume [31], which
supports our “overload” hypothesis. In contrast to our
findings, others did not observe a negative effect of a
presumably less strenuous partially supervised strength
training program on Quality of Well-being [32] which
presumes that the negative effects on some HRQoL-
scales in our study were rather a consequence of the
intensity than of the strength training per se.
The discrepancies in time spent active between the
subjective and objective assessments might be perceived
as a further limitation of the study. However, this dis-
crepancy is possibly related to the already mentioned
different time frame that the two measurement tools
covered and the way accelerometer data were analyzed
that may at least in part have attenuated associations
with HRQoL. In addition, reporting bias based on social
desirability and social approval may have occurred [33].
Furthermore, as this study was a training study, it can-
not be completely excluded that the interaction of the
training supervisors with the participants may have af-
fected some of the associations between the fitness, ac-
tivity and HRQoL variables. Nevertheless, the fact that
there was merely no difference in changes of HRQoL
among groups suggests that this influence was minor.
Finally, there is a possibility of shared variance amongst
a number of the predictor variables in the regression
model explaining HR-QoL that could be responsible for
a reduced association between variables. Yet, this poten-
tial multicollinearity does not reduce the predictive
power or reliability of the model as a whole but rather
affects calculations regarding individual predictors.
Since physical conditioning programs in CF have been
shown to improve pulmonary function, physical fitness
and HRQoL in concert [13,14,29,30,34], patients should
be encouraged to engage in regular at least moderate
physical activities efficient to improve physical fitness even
though we could only show beneficial effects of increased
physical activity on some HRQoL-scales. To maintain or
even improve ‘Vitality’, too strenuous training sessions
without sufficient recovery periods such as unfamiliar
strength training exercises three times per week need to
be avoided in order to not compromise HRQoL.
Conclusions
Health-related quality of life was directly associated with
physical fitness cross-sectionally and longitudinally and, to
a lesser extent, with reported physical activity, BMI and
FEV1. These findings underline the importance of high
physical fitness as a contributor to health-related quality of
life in patients with cystic fibrosis and provide an additional
rationale for exercise testing in this population.
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